Recent Comments
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
- Bill on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (20,313)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (17,029)
- New treatment paradigm for C. Diff colitis (15,210)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,095)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,682)
- How the FDA regulates compounding pharmacies (14,588)
- The Healthcare Channel hits 10 (14,463)
- The new CDC guidelines for prescribing opioid pain pills (9,814)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (9,516)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (9,035)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: – Pharma
Robert De Niro gives credibility to vaccine truthers
Update March 27, 2016- Less than 24-hours after our story, this film has been pulled from the lineup. It was our story that got the heads of
Posted in - Pharma, - Reviews, books, devices, CDC, FDA, NIH, Pediatrics, Primary care medicine
Leave a comment
Are the new PCSK9 cholesterol lowering drugs worth the high cost?
December 16, 2015- Interviewed by Steven E. Greer, MD
Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA
Leave a comment
Martin Shkreli, CEO of Turing Pharmaceuticals, could be the Bernie Madoff of the drug industry
September 22, 2015- by Steven E. Greer, MD Making national news today was Martin Shkreli, the baby-faced, greasy-haired, disheveled-looking
Posted in - Biotech, - Pharma, Congress, FDA
Leave a comment
Rand Paul’s secret Looney Tune side revealed
http://youtu.be/AlWcDDZ1w38 February 2, 2015- By Steven E. Greer, MD People have asked me my opinion of the Republican field for 2016 and I have told them that Dr. Rand
Using Afrezza inhaled insulin with a CGM
November 3, 2014- Interviewed by Steven E. Greer, MD Inhaled insulin will make a comeback when Mannkind’s drug, Afrezza, goes on sale in early 2015.
The FDA’s new Breakthrough status for new drug applications
May 24, 2013- Interviewed by Steven E. Greer, MD Janet Woodcock, MD,
Posted in - Pharma, FDA
Leave a comment
The serious adverse events caused by topical testoserone
March 1, 2014
Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA
Leave a comment
The FDA discusses Brilinta
February 4, 2014- The WSJ is reporting today on a Johns Hopkins doctor who filed a federal
Posted in - Pharma, Cardiology, FDA
Leave a comment
Alex Rodriguez’s PED schedule
January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor
Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology
Leave a comment
CBS allows TV doctor to make egregious claims about statins
Can a “calculator” really tell doctors who should be on Lipitor? Nortin Hadler, MD: lack of evidence for widespread statin use The risk of diabetes associated with statin drugs “You’re telling me this now?” Why the news is suddenly critical … Continue reading
Posted in - Pharma, Cardiology, Cedars Sinai
Leave a comment
New therapies for hepatitis C
November 6, 2013- Interviewed by Steven E. Greer, MD In Part 1, Sammy Saab, MD, MPH, liver disease and GI doctor from UCLA, discusses the standard of care
Super rapid acting insulin and inhaled insulin
September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University
Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami
Leave a comment
FDA reviews the safety of Januvia, Byetta, and other GLP-1 diabetes drugs
Interviewed by Steven E. Greer, MD
Posted in - Pharma, FDA
Leave a comment
anti-PD1 and anti-PD-L1 drugs treating NSCLC
March 26, 2013 Interviewed By Steven E. Greer, MD
Posted in - Biotech, - Pharma, Oncology, UCLA
Leave a comment
The Damon Runyon Cancer Research Foundation panel
March 8, 2013 By Steven E. Greer, MD We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
Paul Richardson, MD: Three-drug regimen for multiple myeloma
December 15, 2015 Dr. Paul Richardson of Harvard’s Dana-Farber Cancer Institute reviews the recent Lancet article
Posted in - Biotech, - Pharma, Harvard, Oncology
Leave a comment
Steven Cummings, MD: The denosumab FREEDOM trial
August 11, 2009- Dr. Steven Cummings, director of the San Francisco Coordinating Center and faculty of UCSF, and
Sundeep Khosla, MD discusses Amgen’s Denosumab
August 11, 2009- Sundeep Khosla of the Mayo Clinic who authored the NEJM editorial on Amgen’s denosumab
Posted in - Biotech, - Pharma, Mayo Clinic
Leave a comment
TIMI 38 and prasugrel
March 3, 2008- by Steven E. Greer, MD One of the more important presentations at the upcoming American College of Cardiology
Posted in - Pharma, Cardiology
Leave a comment